Bangalore Gastro Centre (BGC), which provides specialised care for various digestive illnesses, has inked a Memorandum of Understanding (MoU) with 3BIGS of South Korea, a worldwide healthcare leader in handling Biodata and artificial intelligence...
Roche Diabetes Care India (RDC India) stated that the 'Accu-Chek Active' blood glucose monitoring device is now manufactured in India. In partnership with their manufacturing partner Sanmina-SCI India and assembly and distribution partner Parekh...
At the International Symposium on Precision Oncology and Personalised Medicine, Kokilaben Dhirubhai Ambani Hospital, a pioneer in introducing the latest medical advancements and cutting-edge technologies in cancer care, the hospital announced the...
AstraZeneca Pharma India Ltd announced on Wednesday that the cancer medicine trastuzumab deruxtecan has been approved by the medicine Controller General of India (DCGI) for the treatment of metastatic breast cancer. The company said that it has....
ImaginAb Inc., a global biotechnology company developing the 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent and radiopharmaceutical therapies (RPT), and Quibim, a global company founded with the goal of turning imaging data into...
The US Food and Drug Administration (USFDA) granted tentative approval to Laurus Labs Ltd for the world's first oral dispersible film (ODF) Dolutegravir 5mg and 10mg for paediatric anti-retroviral (ARV) treatment of HIV/AIDS...
Pfizer Inc on beat analysts' estimates for first-quarter profit on strong demand for its newly acquired drugs and steady demand for its COVID products, sending its shares up nearly three per cent before the bell. The company has said it expects...
Acelyrin Inc, a late-stage clinical biopharma company, announced on Monday that it intends to seek a valuation of up to $1.5 billion in its initial public offering in the United States, which comes at a time when new listings are testing...
The US Food and Drug Administration (FDA) has approved Uzedy (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults.Teva Pharmaceuticals' Uzedy is the first FDA-approved subcutaneous, long-acting risperi...
Astellas Pharma of Japan announced on Monday that it has agreed to buy Iveric Bio Inc of the United States for approximately $5.9 billion in its largest acquisition to date, giving it access to a variety of ophthalmology treatments....
, CDSCO.jpg)
